NEPHROGENEX
NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.
NEPHROGENEX
Industry:
Biotechnology Diabetes Health Care
Founded:
2004-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.nephrogenex.com
Total Employee:
11+
Status:
Active
Contact:
609-986-1780
Total Funding:
21.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt WordPress Domain Not Resolving Wordpress Plugins Euro Organization Schema
Similar Organizations
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
East West Bank
East West Bank investment in Post-IPO Equity - NephroGenex
Care Capital
Care Capital investment in Series A - NephroGenex
BioStratum
BioStratum investment in Series A - NephroGenex
Vanderbilt University Office of Investments
Vanderbilt University Office of Investments investment in Series A - NephroGenex
Official Site Inspections
http://www.nephrogenex.com
- Host name: 104.21.88.106
- IP address: 104.21.88.106
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
